Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and Tacrolimus (FK 506)

被引：41
|
作者：
Kramer, MR [1 ]
Merin, G [1 ]
Rudis, E [1 ]
Bar, I [1 ]
Nesher, T [1 ]
Bublil, M [1 ]
Milgalter, E [1 ]
机构：
[1] HADASSAH UNIV HOSP,DEPT CARDIOTHORAC SURG,IL-91120 JERUSALEM,ISRAEL
来源：
TRANSPLANTATION PROCEEDINGS | 1997年 / 29卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(97)00546-0
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2657 / 2659
页数：3
相关论文
共 50 条
  • [1] Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): Efficacy and drug interaction
    Shitrit, D
    Ollech, JE
    Ollech, A
    Bakal, I
    Saute, M
    Sahar, G
    Kramer, MR
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (12): : 2148 - 2152
  • [2] Voriconazole and itraconazole in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction
    Kramer, Mordechai R.
    Amital, Anat
    Fuks, Leonardo
    Shitrit, David
    [J]. CLINICAL TRANSPLANTATION, 2011, 25 (02) : E163 - E167
  • [3] Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Itraconazole Prophylaxis
    Chong, P.
    Hathcock, M.
    Kremers, W.
    Kennedy, C.
    Razonable, R.
    [J]. TRANSPLANTATION, 2014, 98 : 806 - 806
  • [4] Tacrolimus dosage requirements in lung transplant recipients receiving antifungal prophylaxis with voriconazole followed by itraconazole: a preliminary prospective study
    Enderby, Cher Y.
    Heckman, Michael G.
    Thomas, Colleen S.
    Keller, Cesar A.
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (08) : 911 - 915
  • [5] Risk factors of breakthrough aspergillosis in lung transplant recipients receiving itraconazole prophylaxis
    Katada, Yoshiki
    Nakagawa, Shunsaku
    Nagao, Miki
    Yoshida, Yuko
    Matsuda, Yuya
    Yamamoto, Yuki
    Itohara, Kotaro
    Imai, Satoshi
    Yonezawa, Atsushi
    Nakagawa, Takayuki
    Matsubara, Kazuo
    Tanaka, Satona
    Nakajima, Daisuke
    Date, Hiroshi
    Terada, Tomohiro
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (01) : 54 - 60
  • [6] Therapeutic Drug Monitoring in Lung Transplant Recipients Receiving Itraconazole Prophylaxis.
    Chong, P.
    Hathcock, M.
    Kremers, W.
    Kennedy, C.
    Razonable, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 806 - 806
  • [7] Bacterial infections in liver transplant recipients receiving tacrolimus (FK506) as primary immunosuppression.
    Singh, N
    Gayowski, T
    Wagener, MM
    Marino, IR
    [J]. CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) : 327 - 327
  • [8] FLUCONAZOLE THERAPY IN TRANSPLANT RECIPIENTS RECEIVING FK506
    MANEZ, R
    MARTIN, M
    RAMAN, V
    SILVERMAN, D
    JAIN, A
    WARTY, V
    GONZALEZPINTO, I
    KUSNE, S
    STARZL, TE
    [J]. TRANSPLANTATION, 1994, 57 (10) : 1521 - 1523
  • [9] Low-dose fluconazole prophylaxis in kidney transplant recipients receiving tacrolimus
    Sikora, Magdalena B.
    Truax, Crystal
    Lee, Sabrina
    Kenyon, Nicole
    Smith, Lonnie
    Corbett, Jacke
    Shihab, Fuad S.
    [J]. CLINICAL TRANSPLANTATION, 2012, 26 (05) : E555 - E560
  • [10] Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients
    Wallemacq, PE
    Furlan, V
    Möller, A
    Schäfer, A
    Stadler, P
    Firdaous, I
    Taburet, AM
    Reding, R
    De Clety, SC
    De Goyet, JD
    Sokal, E
    Lykavieris, L
    Van Leeuw, V
    Bernard, O
    Otte, JB
    Undre, NA
    [J]. EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (03) : 367 - 370
12345